Health

Lord Grimstone, minister for Investment at the UK’s DIT, spoke at the GCV Symposium

The 10th annual Global Corporate Venturing Symposium marked the first return to Europe of the main corporate, university and government venturing units alongside the rest of the venture capital and startup ecosystem. Its mission is: informing, connecting, and transforming the venture ecosystem.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.

Olympus Innovation Ventures will provide funding for early and growth-stage medical technology developers.

NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.

Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.

Kindred Ventures led the LeFrak-backed healthcare services provider's series E round valuing it at $4.6bn.

Bristol Myers Squibb and Pfizer Ventures are part of a PIPE financing backing the fibrosis and neurodegenerative disease drug developer's reverse takeover.

SAIC Motor’s Hengxu Capital unit took part in the latest round for the Legend Capital-backed X-ray system manufacturer following about $43m in earlier funding.

The corporate-backed fashion and beauty marketplace operator listed on the BSE and NSE in India and reached a market cap of $13.5bn.

Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.